TY - JOUR
T1 - Women's heart disease research in the netherlands
T2 - angina with non-obstructive coronary artery disease and beyond
AU - Dal Canto, Elisa
AU - Onland-Moret, N. Charlotte
AU - Peters, Sanne A.E.
AU - Hummel, Bryn
AU - van Valkengoed, Irene G.
AU - Mommersteeg, Paula M.C.
AU - Roeters-van Lennep, Jeanine
AU - van der Bijl, Marte
AU - Ghossein-Doha, Chahinda
AU - Rutten, Frans H.
AU - Appelman, Yolande
AU - van Oortmerssen, Julie A E
AU - Kavousi, Maryam
AU - Schipaanboord, Diantha J.M.
AU - Jansen, Tijn
AU - Peeters, Denise
AU - Sakkers, Tim R.
AU - de Jong, Elize A.M.
AU - Yosofi, Behruz
AU - van Es, Veroni
AU - Göttgens, Irene
AU - van de Hoef, Tim P.
AU - Oertelt-Prigione, Sabine
AU - Boersma, Eric
AU - Damman, Peter
AU - den Ruijter, Hester M.
PY - 2025/10/29
Y1 - 2025/10/29
N2 - Cardiovascular disease in women has historically been underrepresented in research. In recent years, several funding bodies, including the Dutch Heart Foundation, have launched numerous research initiatives and consortia in the Netherlands to address knowledge gaps in women. This article provides an overview of the current landscape of cardiovascular disease in women and emphasizes the critical need for continued investment in this field. One area with urgent knowledge gaps is the early detection, diagnosis, therapy, and prognosis of Angina with Non-Obstructive Coronary Arteries (ANOCA) in women with persistent signs and symptoms of ischemia. In the Netherlands, in recent years, we have established a robust clinical infrastructure and a translational framework that enables us to address these challenges. Additionally, we have performed implementation studies to fast-track knowledge on ANOCA in clinical practice, giving us a unique opportunity to transform clinical care for women with signs and symptoms of ischemia. We advocate for a broad perspective that incorporates characteristics such as ethnicity, socio-economic background, and female-specific risk factors. Our goal is to provide solid evidence to ensure the best possible care for all women suffering from persistent signs and symptoms of ischemia.
AB - Cardiovascular disease in women has historically been underrepresented in research. In recent years, several funding bodies, including the Dutch Heart Foundation, have launched numerous research initiatives and consortia in the Netherlands to address knowledge gaps in women. This article provides an overview of the current landscape of cardiovascular disease in women and emphasizes the critical need for continued investment in this field. One area with urgent knowledge gaps is the early detection, diagnosis, therapy, and prognosis of Angina with Non-Obstructive Coronary Arteries (ANOCA) in women with persistent signs and symptoms of ischemia. In the Netherlands, in recent years, we have established a robust clinical infrastructure and a translational framework that enables us to address these challenges. Additionally, we have performed implementation studies to fast-track knowledge on ANOCA in clinical practice, giving us a unique opportunity to transform clinical care for women with signs and symptoms of ischemia. We advocate for a broad perspective that incorporates characteristics such as ethnicity, socio-economic background, and female-specific risk factors. Our goal is to provide solid evidence to ensure the best possible care for all women suffering from persistent signs and symptoms of ischemia.
KW - Women’s Health
KW - Coronary Artery Disease
KW - Sex Characteristics
KW - Coronary Heart Disease
KW - Ischemic Heart Disease
KW - Delivery of Health Care
U2 - 10.1007/s12471-025-01997-6
DO - 10.1007/s12471-025-01997-6
M3 - Review article
C2 - 41160340
SN - 1568-5888
JO - Netherlands Heart Journal
JF - Netherlands Heart Journal
ER -
